BJDX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States...

Stats
Šios dienos apimtis	571 313
Vidutinė apimtis	48 417.00
Rinkos kapitalizacija	1.73M
EPS	$0 ( 2024-03-25 )
Kita pelno data	( $-0.720 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0700
ATR14	$0.0150 (2.34%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Dey Svetlana	Buy	500	Common Stock
2023-12-13	Dey Indranil	Buy	500	Common Stock
2023-09-26	Scally Frances P	Buy	0
2023-03-24	Dey Svetlana	Buy	10 000	Common Stock
2023-03-28	Dey Indranil	Buy	2 000	Common Stock

INSIDER POWER
43.51
Last 55 transactions
Buy: 889 772 \| Sell: 456 992

Bluejay Diagnostics, Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
BPYPP	0.971
ISTR	0.97
ADES	0.968
SFBS	0.968
FFWM	0.966
SGMO	0.965
NUWE	0.965
FSEA	0.964
ARVL	0.964
IMBI	0.962

10 Labiausiai neigiamai susiję koreliacijos
MSDA	-0.972
BRIVU	-0.97
VLAT	-0.964
ADAL	-0.962
TIOAU	-0.961
TIOA	-0.96
PPYAU	-0.956
ZING	-0.956
NVCN	-0.953
BRIV	-0.952

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Bluejay Diagnostics, Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$0
Bruto pelnas:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2023
Pajamos:	$0
Bruto pelnas:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2022
Pajamos:	$249 040
Bruto pelnas:	$48 911.00 (19.64 %)
EPS:	$-9.15

FY	2021
Pajamos:	$0.00
Bruto pelnas:	$0.00 (0.00 %)
EPS:	$-0.275

Financial Reports:

No articles found.

Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.